CloudMedX is a company that participated in the YC W15 cohort of Y Combinator and raised an estimated $6,600,000.It streamlines clinical encounters using artificial intelligence to aid health care providers with accurately diagnosing their patients. Its stated goal is to make healthcare accessible and standardized for both patients and doctors.
There are three products available from CloudMedX: the Clinical Analyzer, the Coding Analyzer, and the Consumer Platform. The Clinical Analyzer takes in data on the platform from various contexts, including labs, pharmacies, and electronic medical records. It then uses CloudMedX's artificial intelligence models to formulate clinical insights (such as diagnosing a condition) and operational insights (such as revenue cycle information). The analyzer is capable of making patient risk assessments and provides automated medical documentation.
The Coding Analyzer is a tool that can be used for medical coding and billing. It uses CloudMedX's database to create accurate assessments for healthcare plans. The platform can be utilized by consumers to get vetted health information and materials about how to treat certain conditions.
CloudMedX raises a $5,300,000 venture round from China Equity, Scale Asia Ventures, DraperDragon, Draper Associates and SV Tech Ventures.
CloudMedX was founded by Sahar Arshad, Tashfeen Suleman and Tashfeen Suleman.